Joseph Thome

Stock Analyst at TD Cowen

(0.23)
# 4,220
Out of 4,893 analysts
18
Total ratings
21.43%
Success rate
-29.09%
Average return

Stocks Rated by Joseph Thome

Bright Minds Biosciences
May 13, 2025
Initiates: Buy
Price Target: n/a
Current: $25.93
Upside: -
Viridian Therapeutics
Nov 25, 2024
Initiates: Buy
Price Target: n/a
Current: $17.12
Upside: -
United Therapeutics
Oct 21, 2024
Maintains: Buy
Price Target: $350$400
Current: $300.16
Upside: +33.26%
Rapport Therapeutics
Jul 2, 2024
Initiates: Buy
Price Target: n/a
Current: $15.38
Upside: -
Alkermes
Jun 17, 2024
Initiates: Buy
Price Target: $34
Current: $30.46
Upside: +11.62%
Prime Medicine
Apr 8, 2024
Initiates: Buy
Price Target: n/a
Current: $4.69
Upside: -
Metagenomi
Mar 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $2.21
Upside: -
PTC Therapeutics
Mar 1, 2024
Maintains: Market Perform
Price Target: $32$30
Current: $49.51
Upside: -39.41%
Y-mAbs Therapeutics
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.53
Upside: -
Xenon Pharmaceuticals
Dec 12, 2022
Initiates: Outperform
Price Target: n/a
Current: $32.98
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $1.35
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $5.46
Upside: -
Maintains: Outperform
Price Target: $120$130
Current: $110.73
Upside: +17.40%
Initiates: Outperform
Price Target: n/a
Current: $12.16
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $6.76
Upside: -